
Hydrocortisone Acetate
CAS number: 50-03-3
Molecular formula: C23H32O6
molecular weight: 404.5
Chemical structure:
Producers shown on SFDA
(Record date:21/10/2021)
Producer | Documents | GMP Valid till(based on SFDA) |
Hunan Chengda Biotechnology Co., Ltd. | GMP | Valid till February 2024 |
Producers shown on EP
(Quoted from EP website;record date:21/10/2021)
Substance | Certificate Holder | Certificate Number | Issue Date | Status | End date | Type |
Hydrocortisone acetate | Pharmacia & Upjohn Company Kalamazoo US | R0-CEP 2000-353 - Rev 00 | 24/10/2001 | Withdrawn by Holder | 24/10/2006 | TSE |
Hydrocortisone acetate | TIANJIN TIANYAO PHARMACEUTICALS CO., LTD. Tianjin CN | R1-CEP 2002-121 - Rev 03 | 05/10/2012 | Valid | / | Chemical |
Hydrocortisone acetate | TIANJIN JINJIN PHARMACEUTICAL CO., LTD. Zhangjiawo Town CN | R1-CEP 2008-085 - Rev 00 | 20/10/2016 | Valid | / | Chemical |
Hydrocortisone acetate Micronised | SYMBIOTEC PHARMALAB PRIVATE LIMITED Indore IN | R0-CEP 2016-228 - Rev 00 | 20/09/2018 | Valid | / | Chemical |
Hydrocortisone acetate Process 2 | SANOFI CHIMIE Gentilly FR | R1-CEP 2012-355 - Rev 00 | 08/01/2019 | Valid | / | Chemical |
Hydrocortisone acetate | PHARMACIA & UPJOHN COMPANY LLC Kalamazoo US | R1-CEP 2002-160 - Rev 04 | 29/01/2019 | Valid | / | Chemical |
Hydrocortisone acetate Micronised | SANOFI CHIMIE Gentilly FR | R1-CEP 1996-053 - Rev 07 | 19/06/2019 | Valid | / | Chemical |
Hydrocortisone acetate | Farmabios SpA Gropello Cairoli IT | R0-CEP 2018-171 - Rev 00 | 15/06/2020 | Valid | / | Chemical |
Hydrocortisone acetate | Farmabios SpA Gropello Cairoli IT | R0-CEP 2020-135 - Rev 00 | 15/06/2020 | Valid | / | Chemical |
Hydrocortisone acetate | CURIA SPAIN S.A.U. Boecillo ES | R0-CEP 2019-270 - Rev 01 | 25/08/2021 | Valid | / | Chemical |
Producer:Hunan Chengda Biotechnology Co., Ltd., established in 2002, covers an area of 186 mu, with a total construction area of 72000 square meters and fixed assets of 250 million yuan. It is a high-tech enterprise mainly engaged in steroidal hormone drug raw materials, intermediates and veterinary drugs. According to GMP requirements and advanced EHS management concept, the company has basically formed R & D process, synthetic production The whole industry chain of quality control management is closed-loop, and has obtained GMP certification.
Staff size:100-199 people
Registered capital: RMB 50 million
For supply and market information, please feel free to contact Mr. Paul, paulzhang@yinuopharmchem.com, WhatsApp: +86 18402846978